These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16776848)

  • 1. The MHC2TA -168A>G gene polymorphism is not associated with rheumatoid arthritis in Austrian patients.
    Yazdani-Biuki B; Brickmann K; Wohlfahrt K; Mueller T; März W; Renner W; Gutjahr M; Langsenlehner U; Krippl P; Wascher TC; Paulweber B; Graninger W; Brezinschek HP
    Arthritis Res Ther; 2006; 8(4):R97. PubMed ID: 16776848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MHC2TA -168A/G polymorphism and risk for rheumatoid arthritis: a meta-analysis of 6861 patients and 9270 controls reveals no evidence for association.
    Bronson PG; Criswell LA; Barcellos LF
    Ann Rheum Dis; 2008 Jul; 67(7):933-6. PubMed ID: 17875550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the functional MHC2TA -168 A/G polymorphism and susceptibility to rheumatoid arthritis: a meta-analysis.
    Lee YH; Bae SC
    Clin Rheumatol; 2016 Apr; 35(4):901-9. PubMed ID: 26439834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC2TA promoter polymorphism (-168*G/A, rs3087456) is not associated with susceptibility to rheumatoid arthritis in British Caucasian rheumatoid arthritis patients.
    Harrison P; Pointon JJ; Farrar C; Harin A; Wordsworth BP
    Rheumatology (Oxford); 2007 Mar; 46(3):409-11. PubMed ID: 16920747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC2TA and FCRL3 genes are not associated with rheumatoid arthritis in Mexican patients.
    Mendoza Rincón JF; Rodríguez Elias AK; Fragoso JM; Vargas Alarcón G; Maldonado Murillo K; Rivas Jiménez ML; Barbosa Cobos RE; Jimenez Morales S; Lugo Zamudio G; Tovilla Zárate C; Ramírez Bello J
    Rheumatol Int; 2016 Feb; 36(2):249-54. PubMed ID: 26350270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the MHC2TA gene in autoimmune diseases.
    Martínez A; Sánchez-Lopez M; Varadé J; Mas A; Martín MC; de Las Heras V; Arroyo R; Mendoza JL; Díaz-Rubio M; Fernández-Gutiérrez B; de la Concha EG; Urcelay E
    Ann Rheum Dis; 2007 Mar; 66(3):325-9. PubMed ID: 17012290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the MHC2TA gene, associated with rheumatoid arthritis in a Swedish population, in a UK rheumatoid arthritis cohort.
    Eyre S; Bowes J; Spreckley K; Potter C; Ring S; Strachan D; Worthington J; Barton A
    Arthritis Rheum; 2006 Nov; 54(11):3417-22. PubMed ID: 17075826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction.
    Swanberg M; Lidman O; Padyukov L; Eriksson P; Akesson E; Jagodic M; Lobell A; Khademi M; Börjesson O; Lindgren CM; Lundman P; Brookes AJ; Kere J; Luthman H; Alfredsson L; Hillert J; Klareskog L; Hamsten A; Piehl F; Olsson T
    Nat Genet; 2005 May; 37(5):486-94. PubMed ID: 15821736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism in MHC class II transactivator gene is not associated with susceptibility to colorectal cancer in Swedish patients.
    Mumtaz M; Löfgren S; Hugander A; Dimberg J
    Anticancer Res; 2008; 28(3B):1789-91. PubMed ID: 18630461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism in the MHC2TA gene is associated with features of the metabolic syndrome and cardiovascular mortality.
    Lindholm E; Melander O; Almgren P; Berglund G; Agardh CD; Groop L; Orho-Melander M
    PLoS One; 2006 Dec; 1(1):e64. PubMed ID: 17183695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MHC2TA-168A/G and +1614G/C polymorphisms and risk for multiple sclerosis or chronic inflammatory arthropathies.
    O'Doherty C; Hawkins S; Rooney M; Vandenbroeck K
    Tissue Antigens; 2007 Sep; 70(3):247-51. PubMed ID: 17661914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CIITA gene polymorphism (rs3087456) in systemic lupus erythematosus and rheumatoid arthritis: A population-based cohort study.
    Lima SC; Gomes da Silva IIF; Nascimento DQ; de Moura RR; Mesquita MDS; Asano NMJ; Fernandes GV; Valente LM; Rushansky E; Mariano MHQA; Xavier RM; Chies JAB; Crovella S; Sandrin-Garcia P
    Int J Immunogenet; 2021 Oct; 48(5):429-434. PubMed ID: 34180145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association with rheumatoid arthritis of selected polymorphisms in 4 candidate genes: CFH, CD209, eotaxin-3, and MHC2TA.
    Dieguez-Gonzalez R; Akar S; Calaza M; Gonzalez-Alvaro I; Fernandez-Gutierrez B; Lamas JR; de la Serna AR; Caliz R; Blanco FJ; Pascual-Salcedo D; Velloso ML; Perez-Pampin E; Pablos JL; Navarro F; Narvaez J; Lopez-Longo FJ; Herrero-Beaumont G; Gomez-Reino JJ; Gonzalez A
    J Rheumatol; 2009 Aug; 36(8):1590-5. PubMed ID: 19567623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A polymorphic variant in the MHC2TA gene is not associated with systemic lupus erythematosus.
    Linga-Reddy MV; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Nordmark G; Rönnblom L; Alarcón-Riquelme ME
    Tissue Antigens; 2007 Nov; 70(5):412-4. PubMed ID: 17711409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC2TA single nucleotide polymorphism and genetic risk for autoimmune adrenal insufficiency.
    Ghaderi M; Gambelunghe G; Tortoioli C; Brozzetti A; Jatta K; Gharizadeh B; De Bellis A; Pecori Giraldi F; Terzolo M; Betterle C; Falorni A
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4107-11. PubMed ID: 16849401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The variant rs8048002 T>C in intron 3 of the MHC2TA gene is associated with risk of developing acute coronary syndrome.
    Vargas-Alarcón G; Posadas-Romero C; Posadas-Sánchez R; Martínez-Alvarado R; González-Pacheco H; Martínez-Sánchez C; Martínez-Ríos MA; Juarez-Cedillo T; Ramirez-Fuentes S; Pérez-Méndez O; Fragoso JM
    Cytokine; 2015 Feb; 71(2):268-71. PubMed ID: 25461408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatoid arthritis association with the FCRL3 -169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population.
    Newman WG; Zhang Q; Liu X; Walker E; Ternan H; Owen J; Johnson B; Greer W; Mosher DP; Maksymowych WP; Bykerk VP; Keystone EC; Amos CI; Siminovitch KA
    Arthritis Rheum; 2006 Dec; 54(12):3820-7. PubMed ID: 17133579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter polymorphism rs3087456 in the MHC class II transactivator gene is not associated with susceptibility for selected autoimmune diseases in German patient groups.
    Akkad DA; Jagiello P; Szyld P; Goedde R; Wieczorek S; Gross WL; Epplen JT
    Int J Immunogenet; 2006 Feb; 33(1):59-61. PubMed ID: 16426246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CIITA gene variants are associated with rheumatoid arthritis in Scandinavian populations.
    Eike MC; Skinningsrud B; Ronninger M; Stormyr A; Kvien TK; Joner G; Njølstad PR; Førre O; Flatø B; Alfredsson L; Padyukov L; Undlien DE; Lie BA
    Genes Immun; 2012 Jul; 13(5):431-6. PubMed ID: 22513452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MHC2TA 1614 C>G gene polymorphism is associated with risk of developing acute coronary syndrome.
    Vargas-Alarcón G; Martínez-Ríos MA; Peña-Duque MA; Posadas-Romero C; Cardoso-Saldaña G; Vallejo M; Ramírez-Bello J; Pérez-Méndez O; Fragoso JM
    Mol Immunol; 2013 Oct; 55(3-4):424-8. PubMed ID: 23511026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.